Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor.
about
Functional validation of the oncogenic cooperativity and targeting potential of tuberous sclerosis mutation in medulloblastoma using a MYC-amplified model cell line.IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.Do patients with tuberous sclerosis complex have an increased risk for malignancies?Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy.MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.
P2860
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Metastatic Group 3 Medulloblas ...... Characterization of the Tumor.
@en
Metastatic Group 3 Medulloblas ...... Characterization of the Tumor.
@nl
type
label
Metastatic Group 3 Medulloblas ...... Characterization of the Tumor.
@en
Metastatic Group 3 Medulloblas ...... Characterization of the Tumor.
@nl
prefLabel
Metastatic Group 3 Medulloblas ...... Characterization of the Tumor.
@en
Metastatic Group 3 Medulloblas ...... Characterization of the Tumor.
@nl
P2093
P2860
P50
P356
P1476
Metastatic Group 3 Medulloblas ...... Characterization of the Tumor.
@en
P2093
Assunta Tornesello
Federico Vigevano
Francesca Diomedi Camassei
Massimiliano Valeriani
Paolo Curatolo
P2860
P304
P356
10.1002/PBC.25851
P50
P577
2015-12-02T00:00:00Z